BC Week In Review | Jul 14, 2014
Clinical News

L-Cartin Free Form regulatory update

Otsuka said that Japan approved 100 and 250 mg tablets of L-Cartin FF to treat carnitine deficiencies. Last year, Japan approved the product as an oral solution and injection. The product is an unchlorinated form...
BC Week In Review | Apr 13, 2009
Company News

Sigma-Tau S.p.A., Danisco deal

Sigma-Tau received an exclusive, worldwide license to Danisco's STP-206 , a biologic agent comprised of live bacteria to prevent necrotizing enterocolitis (NEC). NEC is a serious inflammation of intestinal tissues that mostly affects premature infants. Sigma-Tau,...
BC Week In Review | Jan 4, 2000
Clinical News

Carnitor levocarnitine injection regulatory update

The FDA granted marketing approval to Sigma-Tau subsidiary Sigma-Tau Pharmaceuticals Inc. (Gaithersburg, Md.) for Carnitor injection to prevent and treat carnitine deficiency in patients with end stage renal disease undergoing dialysis. Sigma-Tau S.p.A. , Rome, Italy...
Items per page:
1 - 3 of 3